Long-Term Care

CMS proposes to test new Medicare Part B prescription drug models to improve quality of care

MDS 3.0 Insider, March 11, 2016

Want to receive articles like this one in your inbox? Subscribe to MDS 3.0 Insider!

On March 8th, the Centers for Medicare & Medicaid Services (CMS) announced a proposed rule to test new models to improve how Medicare Part B pays for prescription drugs and supports physicians and other clinicians in delivering higher quality care. Medicare Part B covers prescription drugs that are administered in a physician’s office or hospital outpatient department, such as cancer medications, injectables like antibiotics, or eye care treatments. The proposed Medicare Part B Model would test new ways to support physicians and other clinicians as they choose the drug that is right for their patients.

To read more, click here.



Want to receive articles like this one in your inbox? Subscribe to MDS 3.0 Insider!

Most Popular